Webpackaging logo

Tekni-Plex purchases Italian healthcare packaging manufacturer Lameplast

  • Tekni-Plex
Europe, Italy, Beauty, Personal Care, Cosmetics, Health, Pharmaceuticals, Medical, Diagnostics

Tekni-Plex has purchased Italian healthcare packaging company Lameplast SpA from Milan-based private equity firm Aksìa Group. Lameplast will become part of Tekni-Plex’s global Tekni-Films business.

Headquartered in Rovereto sul Secchia near Modena, the company is a leading Italian manufacturer of plastic single/multi-dose containers for pharmaceutical, diagnostic, medical device, veterinary and cosmetic applications, with an emphasis on ophthalmic, vaccine, vaginal and rectal applications. Lameplast is also known for its injection molding, blow molding and injection blow molding expertise which enables it to produce custom packaging solutions for demanding applications.

“We continue to drive our strategy by growing our business organically and through mergers and acquisitions (M&A). We have specifically focused on expanding our healthcare packaging offerings, with M&A in product or technology adjacencies.

Lameplast brings Tekni-Plex specific expertise in unit and multi-dose packaging that was not part of our portfolio previously. We will now be able to offer a rigid packaging solution for prescription and over-the-counter medications and vaccines, in addition to our Tekni-Films flexible packaging options. These products are one more way we can provide value to healthcare and cosmetic companies around the world,” said Paul Young, president and chief executive officer, Tekni-Plex.

The acquisition adds approximately 130 experienced employees to the more than 3,000-strong global Tekni-Plex team. Lameplast General Manager Luca Iulli will continue to oversee the operation.

The company’s quality management system is ISO 15378 and ISO 9001 certified. Lameplast is also a CE-mark holder for Class I medical devices, which indicates compliance with applicable European Union (EU) regulations and enables the commercialization of products in the 32 EU countries. Production is carried out in Class ISO 7 (Class 10,000) and ISO 8 (Class 100,000) controlled contamination environments according to ISO 14644-1.

Lameplast is the twelfth acquisition Tekni-Plex has made in the past five years, supporting its strategy to grow its business though transformative acquisitions and strategic add-ons.

See also

Tekni-Plex business units exhibit latest products at CPHI-InnoPack

Tekni-Plex business units exhibit latest products at CPHI-InnoPack

The latest in films and closure liners for medical device and pharmaceutical applications will be featured by Tekni-Plex business units at CPHI InnoPack, October 24-26, Frankfurt, Germany, stand 42H70. The company’s Tekni-Films business unit will be highlighting its Flexapharm® ultra high-barrier PVDC SBC coating, which offers multiple barrier and economic attributes for pharmaceutical applications, as well as its Aclar® laminates.

Colorite announces North American launch of Cellene thermoplastic elastomer compounds for medical devices

Colorite announces North American launch of Cellene thermoplastic elastomer compounds for medical devices

Colorite, a Tekni-Plex company, is introducing its Cellene line of thermoplastic elastomer compounds to the North American marketplace for medical device applications. Cellene thermoplastic elastomer compounds are suitable for a wide variety of medical devices, as well as packaging and other regulated markets. Cellene compounds are formulated to be silicone, latex, phthalate, halogen and PVC-free using FDA-compliant raw materials to meet USP Class VI and ISO 10993 standards.

  • Company News
  • English
  • Modified 02 Jul 2019
  • Hits 128